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ABSTRACT  
Present work focusing in developing and validating a new high performance liquid chromatography method for estimation of Meto prolol 
Succinate and Benidipine Hydrochloride in their combine tablet dosage form.  The method was performed on Shimadzu LC-20AT instrument 
using C18 (250 mm x 4.6 mm, 5 µm) Hypersil BDS Column and Potassium Dihydrogen Phosphate Buffer (pH 4.0): Methanol (65: 35% v/v) as 
mobile phase at ambient temperature. Detection was carried out at 269 nm. Concentration range 4-12 µg/ml for Benidipine Hydrochloride and 
25-75 µg/ml for Metoprolol Succinate . The Percentage recovery of Benidipine Hydrochloride and Metoprrolol succinate was found to be 
99.59% and 99.39 respectively. Correlation coefficient for Metoprolol succinate and Benidipine Hydrochloride was found 0.9995 and 0.9997 
respectively. The Rt values for Metoprolol succinate and Benidipine Hydrochloride were found to be 3.4 and 5.9 min respectively. The method 
was validated according to the guidelines of International Conference on Harmonisation (ICH) and was successfully employed in the estimation 
of commercial formulations. 
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Metoprolol succinate is Beta-Blocker class of drug and 
chemically it is  bis 1-[4-(2-methoxyethyl) phenoxy]-3-
(propan-2-yl) amino]   propan-2-ol ; butanedioic acid. 1,2,3  
Benidipine hydrochloride is a long acting dihydropyridine 
Ca++  channel blocker and chemically it is O5-methyl O3-
[(3R)-1-(phenylmethyl)piperidin-3-yl] 2,6-dimethyl-4-(3-
nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, 
hydrochloride. 1,2,4  Structure of Metoprolol succinate is 
illustrated in figure I. Structure of Benidipine Hydrochloride 
is illustrated in figure II.  
So far, to our present knowledge a literature survey revealed 
that various methods are reported for the analysis of 
individual drug and in combination with other drugs but any 
RP- HPLC method is not reported for these two drugs in 
combined dosage form.5-27 Therefore, it was thought 
worthwhile to Develop and Validate RP-HPLC methods for 
analysis of Benidipine Hydrochloride and Metoprolol 
Succinate in its Pharmaceutical Dosage Form. 
 
Figure I : Structure of Metoprolol Succinate 
Figure II : Structure of Benidipine Hydrochloride 
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MATERIALS AND METHODS 
Reagents and Chemicals : Metoprolol succinate was 
received as a gift sample from  Intas Pharmaceuticals Pvt. Ltd 
, Ahmedabad and Benidipine Hydrochoride was received as a 
gift sample from Prayosha  Healthcare Pvt. Ltd, Ankleshwar. 
All chemicals and reagents used were a HPLC grade and 
purchased from Merck specialties Pvt., Ltd., Mumbai. 
Combined Tablet Formulation (Benipack- M) was procured 
from Local market. 
Preparation of mobile phase: 
Mobile phase was prepared by mixing 65 ml of Potassium 
Dihydrogen Phosphate Buffer (pH 4.0) and 35 ml of 
methanol and  degas in ultrasonic water bath for 15 minutes. 
Filter through 0.2 μ filter under vacuum filtration before 
injection. 
Chromatographic Conditions: 
 Column :  C18 (250 mm x 4.6 mm, 5 μm) Hypersil BDS  
 Mode of Elution : Isocratic  
 Mobile phase : Potassium Dihydrogen Phosphate Buffer 
(pH 4.0): Methanol (65: 35% v/v) 
 Detection Wavelength : 269 nm  
 Injection volume : 20 μl  
 Flow rate : 1.0 ml/min  
 Column Temperature: 25°C  
 Run time : 07 minutes 
Preparation of Standard stock solution Metoprolol 
Succinate (50 µg/ml) and Benidipine Hydrochloride 
(8µg/ml) 
Accurately weigh and transfer 50 mg of weighed quantity of  
Metoprolol Succinate and 8 mg of Benidipine Hydrochloride  
and dilute it up to 100 ml with Methanol. Further from above 
solution take 1 ml and make the final volume up to 10 ml 
with the use of Methanol to produce 50 µg/ml of Metoprolol 
Succinate and 8µg/ml of Benidipine Hydrochloride . 
Preparation of Standard solution of binary mixtures of 
Metoprolol Succinate  (50 μg/mL) and Benidipine HCl (8 
μg/mL) 
 Form standard stock solution take 1 ml from the Metoprolol 
Succinate Stock solution and 1ml from Benidipine 
Hydrochloride Stock solution  respectively and transferred to 
10 ml volumetric flask and volume was made up to the mark 
by mobile phase. 
Selection of Wavelength: 
 Metoprolol Succinate (50µg/ml) and Benidipine 
Hydrochloride (8µg/ml ) were prepared in Methanol as per 
above mentioned procedure. After that these drug solutions 
were scanned in UV region of 200-400 nm and overlay 
spectrums were recorded. The observed UV Spectra is 
mentioned in figure no. III. From the spectra 269nm was 
selected as a wavelength of detection.  
 
Figure III : Overlay Spectra of Metoprolol Succinate and 
Benidipine Hydrochloride 
Preparation of Calibration Curve : Calibration curves were 
plotted over a concentration range of 4- 12 µg/ml for 
Benidipine Hydrochloride and 25-75 µg/ml for Metoprolol 
Succinate. Accurately measured standard stock solution 
Volume as 5,7.5,10,12.5,15 ml solutions were pipette out from 
the Stock solution of Metoprolol Succinate (500 μg/ml) and 
Benidipine Hydrochloride  (80 μg/ml)  and transfer to 100 ml 
volumetric flask and make up with mobile phase to obtain 
25,37.5,50,62.5 and 75 μg/ml, and 4,6,8,10 and 12μg/ml for 
Metoprolol Succinate and Benidipine Hydrochloride 
respectively.  
Preparation of Sample Stock Solution (Benidipine HCl 80 
μg/mL, Metoprolol Succinate 500 μg/ml ) 
10 tablets were weighed and finely powdered. The average 
weight was calculated. A portion of powder equivalent to the 
weight of one tablet was accurately weighed and transferred 
to a 100 ml volumetric flask. (8mg of Benidipine HCl, and 
50mg of Metoprolol Succinate).  Add 60 ml Mobile phase and 
Shake for 15 min and make up volume with Mobile phase. 
The solution was filtered through Whatman filter paper no.  
42.   
RESULTS AND DISCUSSION: 
Method Validation Parameters: 
The method was validated by establishing linearity, accuracy, 
interday and intraday precision of measurement of sample 
application. The limit of detection and the limit of 
quantification were also determined. Chromatogram of 
Metoprolol succinate and Benidipine Hydrochloride in active 
pharmaceutical ingredients is shown in figure no. IV, V and 
VI. Chromatogram of Metoprolol succinate and Benidipine 
Hydrochloride in Tablet dosage form is shown in figure no. 
VII.
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Figure IV :  Chromatogram o f Benidipine HCl and Metoprolol Succinate in standard solution. 
 
Figure V: Chromatogram of Metoprolol Succinate 
 
Figure VI: Chromatogram of Benidipine HCl 
 
Figure VII :  Chromatogram of Benidipine HCl and Metoprolol Succinate in sample  solution. 
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Method Validation Parameters: 28,29 
Linearity:  
Calibration curve were found to be linear in the range of 25-
75 µg/ml of Metoprolol Succinate and 4-12 µg/ml of 
Benidipine Hydrochloride .Five concentration points were 
assayed in triplicate. Both Metoprolol Succinate and 
Benidipine Hydrochloride showed good linearity in tested 
range. The regression coefficient (R2) value for Metoprolol 
Succinate and Benidipine Hydrochoride were found to be 
0.9995 and 0.9997 respectively. Linear regression data for 
the calibration plots are illustrated in figure no VIII and IX 
respectively. Overlay chromatogram of different 
concentrations of mixtures of Metoprolol Succinate and 
Benidipine Hydrochloride is shown in figure no X. 
 
 
Figure VIII : Calibration Curve o f  Benidipine HCl (4-12 Μg/Ml) 
 
Figure IX : Calibration Curve of Metoprolol Succinate (25-75 ΜG/ML) 
 
Figure X: Overlay Chromatogram of different concentrations of mixtures of Metoprolol Succinate and Benidipine Hydrochloride 
 
Accuracy: Accuracy may often be expressed as % Recovery 
by the assay of known, added amount of analyte. It is 
measure of the exactness of the analytical method. The 
recovery experiments were carried out in triplicate by 
spiking previously analyzed samples of the tablets ( 
Metoprolol succinate and Benidipine Hydrochloride ) with 
three different concentrations of standards at 80 %, 100 % 
and 120%  Metoprolol Succinate ( 20,25 30 µg/ml) and 
Benidipine Hydrochloride (3.2, 4 ,4.8 µg/ml). The % recovery  
were calculated and found to be within the limit as shown in 
table no I. 
 
Table I : % Recovery of Metoprolol Succinate and Benidipine Hydrochloride 
 Conc.  











80% 4 3.2 3.229 100.89 
100% 4 4 4.011 99.59 
120% 4 4.8 4.577 99.105 
Metoprolol 
Succinate 
80% 25 20 19.89 99.43 
100% 25 25 24.09 99.39 
120% 25 30 29.89 99.43 
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Precision :  Intraday Precision was found by analysis of 
standard drug at six times on the same day.While Interday 
Precision was carried out on six different day. The RSD was 
found to be less than 2 for both interday precision and 
intraday Precision. Result for the interday precision and 
intraday precision is shown in table  II , III, IV ,V respectively. 
 
Table II : Intraday Precision Data for estimation of Benidipine HCl 





Mean ± S.D. (n=3) 
% R.S.D 
1 4 911.282 ± 7.622 0.836 
2 8 1834.337 ± 21.617 1.178 
3 12 2573.720± 25.122 0.912 
 
Table III : Intraday Precision data for estimation of Metoprolol Succinate 





Mean ± S.D. (n=3) 
% R.S.D 
1 25 1951.287 ± 13.155 0.674 
2 50 3936.533 ± 25.460 0.647 
3 75 5900.630 ± 37.377 0.633 
 
Table IV : Interday Precision data for estimation of  Benidipine HCl 





Mean ± S.D. (n=3) 
% R.S.D 
1 4 908.023 ± 10.533 1.160 
2 8 1835.168± 16.643 0.907 
3 12 2754.057± 16.371 0.594 
 
Table V : Interday Precision data for estimation of Metoprolol Succinate 





Mean ± S.D. (n=3) 
% R.S.D 
1 25 1948.001 ± 13.549 0.695 
2 50 3922.802± 42.249 1.077 
3 75 5900.556 ± 21.806 0.369 
 
LOD and LOQ :  Limit of Detection and Limit of Quantitation are calculated based on calibration curve and the results are 
shown in table. VI  
Table VI :  Result oF LOD & LOQ for Benidipine HCl & Metoprolol Succinate 
S.N. Name of Drug LOD LOQ 
1 Metoprolol Succinate 1.738 µg/ml 5.266 µg/ml 
2 Benidipine HCl 0.204 µg/ml 0.618 µg/ml 
 
Application of Proposed Method to the Pharmaceutical Dosage Form:  
The Proposed method was applied successfully to the tablet dosage form and results obtained are shown in table VII . 
Table VII : Result  of analysis on marketed formulation 
Tablet Benipack - M 
Label claim Benidipine HCl (4mg) Metoprolol Succinate  (50mg) 
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CONCLUSION:  
A simple rapid, precise and reliable method was developed 
for the estimation of the Benidipine HCl  and Metoprolol 
Succinate in combined dosage forms. The results obtained 
are within the specified limit by the ICH guidelines. 
Analytical column used and the mobile phase provide good 
separation and gives the sharp results. The retention time 
observed for both the drugs was good hence the method can 
be used for routine analysis in quality control laboratories. 
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